Envíos recientes

ÍtemAcceso Abierto
La vulneración de los derechos de la naturaleza y sus consecuencias en la zona de exclusión minera en el cantón Zaruma periodo 2017-2022.
(Universidad Católica de Cuenca., 2025) Tinoco Tinoco, Christian Diego; Martínez Calderón, Karina del Rocío; 0705633717
This article analyzes the violation of the rights of nature within the mining exclusion zone in the canton of Zaruma, province of El Oro, in the period 2017-2022, focusing on legal and socio-environmental aspects regarding illegal and uncontrolled mining. From a qualitative approach, national regulations were examined, emphasizing the Constitution of the Republic of Ecuador, as this was a pioneer at the regional level in recognizing the rights of nature, leaving aside an ancient belief that nature was a property of human beings, that is, it was given the importance of an object but not as a subject of rights, this changed after the reform that was carried out in 2008. Likewise, the research examined how the lack of interim control and the insufficiency in the application of public policies have facilitated negative impacts on ecosystems, affecting biodiversity and causing adverse effects on the environmental balance, in addition to causing setbacks in the development of the local community, leading to irreversible damage to property.
ÍtemAcceso Abierto
Proyecto de Titulación embargado con fines de publicación de impacto.
(Universidad Católica de Cuenca., 2024) Rivera Perez, Adelaida Liduvina; Zabala Espin, Sandra Karina; 1401308323
ÍtemAcceso Abierto
Proyecto de Titulación embargado con fines de publicación de impacto.
(Universidad Católica de Cuenca., 2024) Villa Pando , Juliana Mayreth; Rodríguez Andino, Milagros De La Caridad; 0106586316
ÍtemAcceso Abierto
Eficacia de la enoxaparina versus el rivaroxabán en la prevención del tromboembolismo venoso en trauma ortopédico: revisión sistemática
(Universidad Católica de Cuenca., 2025) Nivelo Alvarez, Paula Renata; Capote Llanares, Miguel Ángel; 0954297040
Venous thromboembolism (VTE) is a condition that leads to the formation of a blood clot in a blood vessel, which can travel and eventually block blood flow, endangering the patient’s life. Objective: To analyze the efficacy of enoxaparin versus rivaroxaban in preventing venous thromboembolism in orthopedic trauma. Methodology: A systematic review with a descriptive design and mixed approach was conducted following the PRISMA method parameters, analyzing 22 articles from scientific sources such as PubMed, Scopus, Lilacs, Redalyc, SciELO, and Web of Science. Results: Obesity, smoking, hypertension, diabetes, a history of venous thrombosis, and hospitalization were the predominant risk factors. Additionally, women over 60 years old were prevalent in both groups. The administered dose of enoxaparin was 40 mg/day for durations of 10, 14, 30, 35, and 90 days, while the daily dose of rivaroxaban was 10 mg for 7, 14, 35, 42, and 90 days. Enoxaparin reduced the risk of deep vein thrombosis (DVT) to 2.11% and pulmonary embolism (PE) to 0.57%. Rivaroxaban reduced DVT to 2.30% and PE to 0.13%. Both medications were well-tolerated by patients, though they presented common adverse effects such as bleeding at a low incidence. Conclusions: Both drugs effectively prevent VTE, but rivaroxaban revealed greater efficacy in preventing PE and did not present mortality cases. Keywords: venous thromboembolism, adverse effects, prevention, enoxaparin, rivaroxaban
ÍtemAcceso Abierto
Eficacia de la hidralazina versus nifedipino en el tratamiento de la preeclampsia: revisión sistemática
(Universidad Católica de Cuenca., 2025) Benalcázar Urgiles, Patricia Jacqueline; Naula Morocho, Johanna Veronica; Gallegos Vintimilla, Santiago Homero; 0107130221; 0106182850
Background: Among the most commonly used drugs in pregnant women diagnosed with preeclampsia are hydralazine and nifedipine. Their efficacy, as well as their onset of action, has been demonstrated to reach optimal levels. Their use is widespread, though not without concerns about adverse maternal and perinatal effects. Objective: To characterize the efficacy of hydralazine versus nifedipine in treating preeclampsia. Methodology: A systematic literature review was conducted involving searches in health databases, primarily PubMed, Elsevier, and SpringerLink, using predefined descriptors supported by Boolean operators such as AND and OR to optimize the searches. The PRISMA methodology was employed for screening and selection processes. All articles included were published after 2020 in English or Spanish as essential inclusion criteria. Sixty-four references met the established requirements, and 57 were included in the final bibliography. Results: Twelve articles met the screening and suitability processes according to the designed objectives. The onset of action of both medications varied depending on the doses. Hydralazine demonstrated a slightly faster onset compared to nifedipine. Regarding efficacy levels, both drugs showed optimal results. However, nifedipine was associated with a higher incidence of adverse effects. Conclusions: Hydralazine proved to be faster in its action. Both drugs achieved appropriate levels of efficacy, although nifedipine revealed a more significant number of adverse effects. Keywords: antihypertensives, hydralazine, hypertension, nifedipine, preeclampsia
logo ucacue
Universidad Católica de Cuenca

Teléfonos:

593 (07) 2-830-7512-830-8772-824-365

Email:

info@ucacue.edu.ecCentro de documentación
logo rraae
logo la referencia